Etizolam in the Treatment of Generalized Anxiety Disorder: A Controlled Clinical Trial

  title={Etizolam in the Treatment of Generalized Anxiety Disorder: A Controlled Clinical Trial},
  author={A. Bertolino and E. Mastucci and V. Porro and L. Corfiati and M. Palermo and U. Ecari and G. Ceccarelli},
  journal={Journal of International Medical Research},
  pages={455 - 460}
  • A. Bertolino, E. Mastucci, +4 authors G. Ceccarelli
  • Published 1989
  • Medicine
  • Journal of International Medical Research
  • A total of 45 patients with generalized anxiety disorder were treated twice daily for 2 weeks, on a double-blind basis, with 0.5 mg etizolam, 0.5 mg alprazolam or 3 mg bromazepam, and symptoms were assessed using Hamilton's rating scale for anxiety and Hamilton's rating scale for depression. Patients then received the same drug for a further 2 weeks, the drugs being given three times daily if a poor response was observed during the first 2 weeks. All drugs displayed equivalent anxiolytic… CONTINUE READING
    9 Citations
    Treatments for generalized anxiety disorder
    • 20
    Amnestic and anxiolytic effects of alprazolam in oral surgery patients.
    • 18
    Role of Benzodiazepines in Anxiety Disorders.
    Auditory Hallucinations Suppressed by Etizolam in a Patient with Schizophrenia
    • 4


    Psychopharmacology of the anxiety disorders.
    • J. Ballenger
    • Psychology, Medicine
    • The Psychiatric clinics of North America
    • 1984
    • 24
    The drug treatment of anxiety and depression.
    • J. Cole
    • Medicine
    • The Medical clinics of North America
    • 1988
    • 5
    Rational Use of Anxiolytic/Sedative Drugs
    • 35
    A comparison of panic disorder and generalized anxiety disorder.
    • 163
    Acute, subacute and chronic toxicity of etizolam
    • Pharmacometrics
    • 1978
    BrembiIlaE, etal: Studio delle proprieta farmacologiche dell'etizolam
    • Minerva Psichiatr
    • 1984